41 related articles for article (PubMed ID: 8504733)
1. Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway.
Harada S; Smith RM; Smith JA; Jarett L
Endocrinology; 1993 Jun; 132(6):2293-8. PubMed ID: 8504733
[TBL] [Abstract][Full Text] [Related]
2. Nuclear shield: a multi-enzyme task-force for nucleus protection.
Fabrini R; Bocedi A; Pallottini V; Canuti L; De Canio M; Urbani A; Marzano V; Cornetta T; Stano P; Giovanetti A; Stella L; Canini A; Federici G; Ricci G
PLoS One; 2010 Dec; 5(12):e14125. PubMed ID: 21170318
[TBL] [Abstract][Full Text] [Related]
3. Cytosolic Uptake of Large Monofunctionalized Dextrans.
Chyan W; Kilgore HR; Raines RT
Bioconjug Chem; 2018 Jun; 29(6):1942-1949. PubMed ID: 29649361
[TBL] [Abstract][Full Text] [Related]
4. Exchange Broadening Underlies the Enhancement of IDE-Dependent Degradation of Insulin by Anionic Membranes.
Zheng Q; Lee B; Kebede MT; Ivancic VA; Kemeh MM; Brito HL; Spratt DE; Lazo ND
ACS Omega; 2022 Jul; 7(28):24757-24765. PubMed ID: 35874268
[TBL] [Abstract][Full Text] [Related]
5. Insulin-degrading enzyme.
Authier F; Posner BI; Bergeron JJ
Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82.
Harada S; Smith RM; Hu DQ; Jarett L
Biochem Biophys Res Commun; 1996 Jan; 218(1):154-8. PubMed ID: 8573122
[TBL] [Abstract][Full Text] [Related]
7. Insulin-Degrading Enzyme Regulates the Proliferation and Apoptosis of Porcine Skeletal Muscle Stem Cells
Wang B; Guo J; Zhang M; Liu Z; Zhou R; Guo F; Li K; Mu Y
Front Cell Dev Biol; 2021; 9():685593. PubMed ID: 34712657
[TBL] [Abstract][Full Text] [Related]
8. Insulin-Degrading Enzyme: Paradoxes and Possibilities.
Leissring MA
Cells; 2021 Sep; 10(9):. PubMed ID: 34572094
[TBL] [Abstract][Full Text] [Related]
9. Targeting Insulin-Degrading Enzyme in Insulin Clearance.
Leissring MA; González-Casimiro CM; Merino B; Suire CN; Perdomo G
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668109
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.
González-Casimiro CM; Merino B; Casanueva-Álvarez E; Postigo-Casado T; Cámara-Torres P; Fernández-Díaz CM; Leissring MA; Cózar-Castellano I; Perdomo G
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33477364
[TBL] [Abstract][Full Text] [Related]
11. Effect of Passage Number and Culture Time on the Expression and Activity of Insulin-Degrading Enzyme in Caco-2 Cells.
Mohammadi Farsani T; Motevaseli E; Neyazi N; Khorramizadeh MR; Zafarvahedian E; Ghahremani MH
Iran Biomed J; 2018 Jan; 22(1):70-5. PubMed ID: 28710847
[TBL] [Abstract][Full Text] [Related]
12. Intracellular insulin in human tumors: examples and implications.
Radulescu RT
Diabetol Metab Syndr; 2011 Apr; 3(1):5. PubMed ID: 21457557
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}.
Zhao WQ; Lacor PN; Chen H; Lambert MP; Quon MJ; Krafft GA; Klein WL
J Biol Chem; 2009 Jul; 284(28):18742-53. PubMed ID: 19406747
[TBL] [Abstract][Full Text] [Related]
14. Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.
Yfanti C; Mengele K; Gkazepis A; Weirich G; Giersig C; Kuo WL; Tang WJ; Rosner M; Schmitt M
Int J Mol Med; 2008 Oct; 22(4):421-31. PubMed ID: 18813847
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines.
Weirich G; Mengele K; Yfanti C; Gkazepis A; Hellmann D; Welk A; Giersig C; Kuo WL; Rosner MR; Tang WJ; Schmitt M
Biol Chem; 2008 Nov; 389(11):1441-5. PubMed ID: 18783335
[TBL] [Abstract][Full Text] [Related]
16. Study on the possibility of insulin as a carrier of IUdR for hepatocellular carcinoma-targeted therapy.
Ou XH; Kuang AR; Peng X; Zhong YG
World J Gastroenterol; 2003 Aug; 9(8):1675-8. PubMed ID: 12918099
[TBL] [Abstract][Full Text] [Related]
17. Cellular distribution of insulin-degrading enzyme gene expression. Comparison with insulin and insulin-like growth factor receptors.
Bondy CA; Zhou J; Chin E; Reinhardt RR; Ding L; Roth RA
J Clin Invest; 1994 Mar; 93(3):966-73. PubMed ID: 8132782
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.
Harada S; Smith RM; Smith JA; Shah N; Jarett L
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):21-8. PubMed ID: 7864812
[TBL] [Abstract][Full Text] [Related]
19. In vivo iodination of a misfolded proinsulin reveals co-localized signals for Bip binding and for degradation in the ER.
Schmitz A; Maintz M; Kehle T; Herzog V
EMBO J; 1995 Mar; 14(6):1091-8. PubMed ID: 7720700
[TBL] [Abstract][Full Text] [Related]
20. Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2).
Bai JP; Hsu MJ; Shier WT
Pharm Res; 1995 Apr; 12(4):513-7. PubMed ID: 7596985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
